Astellas Pharma Inc. et al v. Sawai Pharmaceutical Co. Ltd. et al
| Sawai Pharmaceutical Co. Ltd. and Sawai USA Inc. |
| Astellas Pharma Inc., Astellas Ireland Co., Ltd. and Astellas Pharma Global Development, Inc. |
| 1:2022cv00818 |
| June 17, 2022 |
| US District Court for the District of Delaware |
| Joseph F Bataillon |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. § 271 Patent Infringement |
| Defendant |
Docket Report
RSS Track this Docket
This docket was last retrieved on August 9, 2022. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 14 ANSWER to #12 Answer to Complaint, Counterclaim by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc..(Silver, Daniel) |
| Filing 13 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Sawai Group Holdings Ltd. for Sawai Pharmaceutical Co. Ltd., Sawai USA Inc. filed by Sawai Pharmaceutical Co. Ltd., Sawai USA Inc.. (Gattuso, Dominick) |
| Filing 12 ANSWER to #1 Complaint, with Jury Demand Affirmative Defenses, COUNTERCLAIM against All Plaintiffs by Sawai USA Inc., Sawai Pharmaceutical Co. Ltd..(Gattuso, Dominick) |
| Filing 11 DECLARATION of Service on Sawai Pharmaceutical Co., Ltd. by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Attachments: #1 Exhibits A - B)(Silver, Daniel) |
| Filing 10 DECLARATION of Service on Sawai Pharmaceutical Co., Ltd. by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Attachments: #1 Exhibits A - B)(Silver, Daniel) |
| Filing 9 DECLARATION of Service on Sawai USA, Inc. by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Attachments: #1 Exhibits A - B)(Silver, Daniel) |
| Filing 8 DECLARATION of Service on Sawai USA, Inc. by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Attachments: #1 Exhibits A - B)(Silver, Daniel) |
Filing 7
ORAL ORDER - Pursuant to the filing of this case, the Court issues the following order: Magistrate Judge Burke shall issue a scheduling order when appropriate. Magistrate Judge Burke shall handle all nondispositive matters on all issues, except for Daubert motions, Markman hearings, and pretrial motions in limine. The parties have the right to file an appeal of the magistrate judge's order, and the same shall be decided by the undersigned. The magistrate judge shall likewise handle all discovery matters, scheduling, and pretrial conferences. If the parties believe the magistrate judge has a conflict of interest with this case, the parties shall so notify the Court. IT IS SO ORDERED. Signed by Judge Joseph F. Bataillon on 06/29/2022. (AEV)
|
| Case Assigned to Judge Joseph F. Bataillon of the United States District Court for the District of Nebraska, due to related cases. Please include the initials of the Judge (JFB) after the case number on all documents filed. (rjb) |
| Filing 6 Summons Issued as to Sawai Pharmaceutical Co. Ltd. on 6/17/2022; Sawai USA Inc. on 6/17/2022. (srs) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Astellas B.V. for Astellas Ireland Co., Ltd.; Corporate Parent Astellas US Holding, Inc. for Astellas Pharma Global Development, Inc. filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc. (srs) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,346,532 ; 7,342,117 ; 7,982,049 ; 8,835,474 ; 10,842,780 and RE44,872. (srs) (Attachment(s) #1 Patent/Trademark Report) (srs). |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: No Earlier than May 24, 2022. Date of Expiration of Patent: See Attached. Thirty Month Stay Deadline: No Earlier than November 24, 2024. (srs) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (srs) |
| Filing 1 COMPLAINT FOR PATENT INFRINGEMENT filed against Sawai Pharmaceutical Co. Ltd., Sawai USA Inc. ( Filing fee $ 402, receipt number ADEDC-3898570.) - filed by Astellas Pharma Inc., Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc.. (Attachments: #1 Exhibit A-F, #2 Civil Cover Sheet)(srs) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
